CYCLIC COMPOUNDS AND METHODS OF USING SAME

The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof which are MALT1 inhibitors. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts ther...

Full description

Saved in:
Bibliographic Details
Main Authors Krilov, Goran, Placzek, Andrew, Trzoss, Michael, Lagiakos, H. Rachel, Nie, Zhe, Trzoss, Lynnie, Feng, Shulu, Lawrenz, Morgan, Tang, Haifeng
Format Patent
LanguageEnglish
Published 18.01.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof which are MALT1 inhibitors. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases, such as cancer, autoimmune disorders, and inflammatory disorders.
AbstractList The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof which are MALT1 inhibitors. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases, such as cancer, autoimmune disorders, and inflammatory disorders.
Author Lawrenz, Morgan
Lagiakos, H. Rachel
Trzoss, Lynnie
Nie, Zhe
Tang, Haifeng
Krilov, Goran
Placzek, Andrew
Trzoss, Michael
Feng, Shulu
Author_xml – fullname: Krilov, Goran
– fullname: Placzek, Andrew
– fullname: Trzoss, Michael
– fullname: Lagiakos, H. Rachel
– fullname: Nie, Zhe
– fullname: Trzoss, Lynnie
– fullname: Feng, Shulu
– fullname: Lawrenz, Morgan
– fullname: Tang, Haifeng
BookMark eNrjYmDJy89L5WTQco509vF0VnD29w3wD_VzCVZw9HNR8HUN8fAHsv3dFEKDPf3cFYIdfV15GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8aLCRgZGJgaGFoam5o6ExcaoAv7cnFg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2024018157A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2024018157A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:56:28 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2024018157A13
Notes Application Number: US202017787835
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240118&DB=EPODOC&CC=US&NR=2024018157A1
ParticipantIDs epo_espacenet_US2024018157A1
PublicationCentury 2000
PublicationDate 20240118
PublicationDateYYYYMMDD 2024-01-18
PublicationDate_xml – month: 01
  year: 2024
  text: 20240118
  day: 18
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies Schrödinger, Inc
RelatedCompanies_xml – name: Schrödinger, Inc
Score 3.5248573
Snippet The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof which are MALT1 inhibitors. The...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title CYCLIC COMPOUNDS AND METHODS OF USING SAME
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240118&DB=EPODOC&locale=&CC=US&NR=2024018157A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSB0FcbfqxhyJd2lrFfmBbmU9jaSMIMoer-O97CZ3uaW-XBC4fcB-_S-4CcKlPbavmQ0QnAiEKvbVr1IPTN8Q8aF64bdJaBfTjxIpK-jg2xx34WObCqDqhP6o4IkpUhfLeKH09_w9i-ept5eKGv2PX511YuL7WomM0T-gwa_7IDbLUT5nGmFvmWvLcjjm6aXuIlTakIy0r7QcvI5mXMl81KuEubGbIb9bsQUfMerDNln-v9WArbq-8kWylb7EPV-yVPT0wwtI4S8vEz4mX-CQOiihFOg2J_EPjnuReHBzARRgULLrGSSd_e5yU-eoKjUPoIvoXR0CMmvNaVBaqIUqNQYUIqRo66GWawh5Qah5Dfx2nk_XDp7AjmzKmoDt96DZf3-IMrWzDz9Xh_AKSeHqs
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq-KjakDJQRBbs8mmhyDpJjHVJBtMIu0pNA9BkFpsxL_vbEi1p96WHZh9wDy-2Z0ZgOvBjGpFNkR0UiJEIfe0QD04e0PMg-Yloyop6oC-H2huQp4m6qQFH6tcmLpO6E9dHBElKkd5r2p9vfgPYln138rlXfaOU58PTmxYcoOO0TyhwyxbI8MOucWZzJiRRHLw0tD0gUpNxEpbVNTnFc7T60jkpSzWjYqzB9sh8ptX-9Aq513osFXvtS7s-M2TNw4b6VsewA2bMm_MJMb9kCeBFUlmYEm-Hbscx9yRRA-NRykyffsQrhw7Zu4tLpr-nTFNovUdKkfQRvRfHoOkFFlWlLmGaogQpZ8jQsqHOnqZakn7hKgn0NvE6XQz-RI6bux7qTcOns9gV5BEfGGg96BdfX2X52hxq-yivqhfdzZ9mQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CYCLIC+COMPOUNDS+AND+METHODS+OF+USING+SAME&rft.inventor=Krilov%2C+Goran&rft.inventor=Placzek%2C+Andrew&rft.inventor=Trzoss%2C+Michael&rft.inventor=Lagiakos%2C+H.+Rachel&rft.inventor=Nie%2C+Zhe&rft.inventor=Trzoss%2C+Lynnie&rft.inventor=Feng%2C+Shulu&rft.inventor=Lawrenz%2C+Morgan&rft.inventor=Tang%2C+Haifeng&rft.date=2024-01-18&rft.externalDBID=A1&rft.externalDocID=US2024018157A1